Avinash Kumbharkar  एक नया लेख बनाया
2 में ·अनुवाद करना

The Commercial Trajectory of Multiplex PCR vs. Metagenomic Sequencing: Analyzing 2026 Trends in Unbiased Pathogen Detection (2025–2032) | #syndromic Multiplex Diagnostic Market

The Commercial Trajectory of Multiplex PCR vs. Metagenomic Sequencing: Analyzing 2026 Trends in Unbiased Pathogen Detect

The Commercial Trajectory of Multiplex PCR vs. Metagenomic Sequencing: Analyzing 2026 Trends in Unbiased Pathogen Detect

The global Syndromic Multiplex Diagnostic Market in 2026 is at the forefront of precision medicine. Moving away from traditional "one-test, one-pathogen" protocols, healthcare providers are increasingly adopting a "symptoms-first" approach. This allow clinicians to